Prevention of preterm labor with hydroxyprogesterone caproate (17OHP): does conversion from compounded to commercial formulation change health system resource utilization and patient access?

被引：0

作者：

Falk, Kristina ^{[1
]}

Bobowski, Christie ^{[1
]}

Doshi, Anisha ^{[1
]}

Abdou, Sherif ^{[2
]}

Stone, Rebecca ^{[3
]}

机构：

[1] Univ Illinois, Coll Pharm, Ctr Womens Hlth, Pharm Practice, Chicago, IL USA

[2] Univ Illinois Hosp & Hlth Sci Syst, Pharm Practice, Ctr Womens Hlth, Chicago, IL USA

[3] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA

来源：

PHARMACOTHERAPY | 2015年 / 35卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

152

引用

页码：E210 / E210

页数：1